2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$17.98+$0.10 (+0.53%)
Price as of Jun 23, 2026 7:56 PM EDT- $2.3BMarket Cap
- 123.88%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$17.98+$0.10 (+0.53%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 271.3M +15.40% | 235.1M +33.97% | 175.5M +30.95% | 134.0M +193.89% | |
Cost of Revenue | 32.7M +15.64% | 28.2M +99.66% | 14.1M +149.79% | 5.7M +419.16% | |
Gross Profit | 238.7M +15.37% | 206.9M +28.21% | 161.4M +25.71% | 128.4M +188.37% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | 15.4M -5.52% | 16.3M -90.49% | |
Research and Development Expense | -32.5M +56.39% | -20.8M -58.13% | -49.6M +10.34% | -45.0M -12.03% | |
Depreciation and Amortization Expense | 19.4M +0.02% | 19.4M +66.95% | 11.6M +330.41% | 2.7M +28.98% | |
Total Operating Expenses | 178.1M -25.72% | 239.8M -10.25% | 267.2M +8.84% | 245.5M +8.47% | |
Operating Profit | 104.9M +2,338.40% | -4.7M -94.89% | -91.7M -17.74% | -111.5M -38.32% | |
Interest Income | 13.6M -20.02% | 17.0M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -2.8M N/A | N/A N/A | |
Interest Income and Expense and Net | 13.6M -20.02% | 17.0M +711.53% | -2.8M N/A | 0 -100.00% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 17.0M +232.10% | 5.1M N/A | |
Income before Taxes | 114.2M +1,432.72% | 7.4M +109.61% | -77.5M -27.16% | -106.4M -40.98% | |
Income Taxes | -173.0M -10,303.12% | 1.7M +207.80% | 551,000 -69.86% | 1.8M +140.53% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 287.2M +4,893.08% | 5.8M +107.37% | -78.0M -27.88% | -108.2M -40.22% | |
Net Income from Continuing Operations Applicable to Common | 114.2M +1,432.72% | 7.4M +109.61% | -77.5M -27.16% | -106.4M -40.98% | |
Basic EPS and Net Income | 2.14 +5,250.00% | 0.04 +107.41% | -0.54 -28.95% | -0.76 -45.71% | |
Diluted EPS and Net Income | 2.07 +5,075.00% | 0.04 +107.41% | -0.54 -28.95% | -0.76 -45.71% | |
Basic Weighted Average Shares | 134.4M -6.07% | 143.1M -0.12% | 143.2M +0.93% | 141.9M +9.70% | |
Diluted Weighted Average Shares | 138.7M -5.13% | 146.2M +2.07% | 143.2M +0.93% | 141.9M +9.70% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 80.2M -3.86% | 83.4M +70.71% | 48.9M -48.10% | 94.2M -59.39% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 80.2M -3.86% | 83.4M +70.71% | 48.9M -48.10% | 94.2M -59.39% | |
Total Current Assets | 492.0M +10.16% | 446.6M +5.13% | 424.8M -4.01% | 442.5M -13.79% | |
Accumulated Depreciation | 3.2M +24.48% | 2.5M +32.62% | 1.9M +31.27% | 1.5M +74.04% | |
Property and Plant and Equipment and Net | 2.1M -22.70% | 2.7M -18.57% | 3.4M -8.11% | 3.6M -17.38% | |
Total Long-Term Assets | 93,000 -88.70% | 823,000 -45.75% | 1.5M -88.63% | 13.3M +12.68% | |
Total Assets | 751.6M +36.49% | 550.6M +0.47% | 548.1M +16.40% | 470.9M -13.34% | |
Income Taxes Payable | 2.0M N/A | N/A N/A | 667,000 +6.72% | 625,000 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 93.7M -4.13% | 97.8M +26.66% | 77.2M +67.41% | 46.1M +13.44% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 17.5M +57.99% | 11.1M +1.80% | 10.9M -10.32% | 12.2M -23.72% | |
Total Liabilities | 170.3M -1.68% | 173.2M +1.80% | 170.1M +160.00% | 65.4M +1.79% | |
Retained Earnings | -649.4M -30.67% | -936.6M -0.61% | -942.3M +9.03% | -864.3M +14.31% | |
Total Stockholders Equity | 581.3M +54.00% | 377.5M -0.13% | 378.0M -6.78% | 405.4M -15.37% | |
Total Shares Outstanding | 132.3M -6.08% | 140.9M -2.05% | 143.8M +1.10% | 142.3M +0.47% | |
Cash Flow | |||||
Cash from Operating Activities | 135.7M +205.62% | 44.4M +232.66% | -33.5M -57.93% | -79.5M -49.57% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -32.8M -183.46% | 39.3M +685.48% | -6.7M -88.94% | -60.6M -41.63% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -106.1M +116.15% | -49.1M +856.96% | -5.1M -310.85% | 2.4M -98.90% | |
Financials Ratio | |||||
Gross Margin | 87.96% -0.03% | 87.99% -4.30% | 91.94% -4.00% | 95.77% -1.88% | |
Operating Margin | 38.66% +2,039.72% | -1.99% -96.18% | -52.24% -37.19% | -83.17% -79.01% | |
Return on Assets | 44.11% +4,112.91% | 1.05% +106.84% | -15.31% -28.21% | -21.33% -40.65% | |
Return on Equity | 59.91% +3,834.08% | 1.52% +107.65% | -19.92% -18.57% | -24.46% -40.06% | |
Revenue Growth | 15.40% -54.66% | 33.97% +9.75% | 30.95% -84.04% | 193.89% +2,253.24% | |
Current Ratio | 5.25 +14.91% | 4.57 -16.99% | 5.50 -42.66% | 9.60 -24.00% | |
Cash Ratio | 0.86 +0.28% | 0.85 +34.78% | 0.63 -69.00% | 2.04 -64.20% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow